未找到相关数据
First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER2-negative or recurrent mBC: First PFS analysis.
被引：0
作者：
Salvador, J.
Jaen, A.
Ciruelos, E. M.
Codes, M.
Gil, M.
Murias, A.
Galan, A.
De la Haba, J. R.
Jara, C.
Bayo, J. L.
Baena, J. M.
Casal, J.
Mel, J. R.
Blancas, I.
Gonzalez, E.
Perez, D.
Manso, L.
机构：
[1] Hosp Virgen de Valme, Seville, Spain
[2] Hosp Jaen, Jaen, Spain
[3] Hosp Univ 12 Octubre, Madrid, Spain
[4] Hosp Virgen de la Macarena, Seville, Spain
[5] Catalan Inst Oncol Duran & Reynals, Barcelona, Spain
[6] Hosp Univ Insular Gran Canaria, Las Palmas Gran Canaria, Spain
[7] Hosp Sagunto, Sagunto, Spain
[8] Hosp Reina Sofia, Cordoba, Spain
[9] Fdn Hosp Alcorcon, Alcorcon, Spain
[10] Hosp Juan Ramon Jimenez, Huelva, Spain
[11] Hosp Puerta del Mar, Cadiz, Spain
[12] Complexo Hosp Univ Vigo, Vigo, Spain
[13] Complejo Hosp Xeral Calde, Lugo, Spain
[14] Hosp Clin San Cecilio, Granada, Spain
[15] Hosp Virgen de las Nieves, Granada, Spain
[16] Hosp Costa del Sol, Marbella, Spain
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.1112
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1112
引用
收藏
页数：1
相关论文